MOH
MOLINA HEALTHCARE, INC.
+6.35 (+3.14%)208.57USD173K成交股數10.9B市值1158.7本益比(近四季)0.2股價營收比-4.8%營收年增(近四季)2026-10-21下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | 10.9B-5% | 10.8B-3% | 11.4B+10% | 11.5B+16% | 11.4B+15% | 11.1B+23% | 10.3B+21% | 9.9B+19% | 9.9B | 9.0B | 8.5B | 8.3B |
| 營業成本 | 9.4B | 9.3B | 10.1B | 10.0B | 9.8B | 9.5B | 8.6B | 8.4B | 8.4B | 7.5B | 7.3B | 7.0B |
| 毛利 | 1.4B-10% | 1.5B-9% | 1.2B-27% | 1.4B-5% | 1.6B+5% | 1.7B+5% | 1.7B+37% | 1.5B+17% | 1.5B | 1.6B | 1.2B | 1.3B |
| 毛利率 | 13.2% | 14.1% | 10.9% | 12.5% | 14.0% | 15.0% | 16.4% | 15.3% | 15.3% | 17.6% | 14.5% | 15.5% |
| 研發費用 | – | – | – | – | – | – | – | – | – | – | – | – |
| 銷售管理費用 | 724M | 779M | 795M | 729M | 711M | 774M | 676M | 691M | 711M | 645M | 608M | 618M |
| 營業利益 | 145M-61% | 83.0M-81% | −162M-135% | 137M-68% | 373M-12% | 433M+37% | 467M+30% | 434M-2% | 426M | 316M | 359M | 443M |
| 營業利益率 | 1.3% | 0.8% | -1.4% | 1.2% | 3.3% | 3.9% | 4.5% | 4.4% | 4.3% | 3.5% | 4.2% | 5.3% |
| 稅後淨利 | 60.0M-76% | 14.0M-95% | −160M-149% | 79.0M-74% | 255M-15% | 298M+38% | 326M+33% | 301M-3% | 301M | 216M | 245M | 309M |
| 淨利率 | 0.6% | 0.1% | -1.4% | 0.7% | 2.2% | 2.7% | 3.2% | 3.0% | 3.0% | 2.4% | 2.9% | 3.7% |
| 稀釋 EPS | 1.19-75% | 0.27-95% | -2.79-149% | 1.51-71% | 4.75-8% | 5.45+48% | 5.65+34% | 5.17-3% | 5.17 | 3.69 | 4.21 | 5.35 |
| 稀釋股數 | 51.3M | 51.0M | 52.9M | 52.5M | 53.7M | 54.8M | 57.7M | 58.2M | 58.3M | 58.1M | 58.1M | 57.9M |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 5.0B | 5.3B | 4.2B | 4.2B | 4.5B | 4.9B | 4.7B | 4.4B | 4.5B | 4.8B | 5.6B | 4.9B |
| 應收帳款 | 3.5B | 3.4B | 3.5B | 3.5B | 3.9B | 3.5B | 3.3B | 3.2B | 3.4B | 3.1B | 2.5B | 2.4B |
| 存貨 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總資產 | 16.0B | 16.4B | 15.6B | 15.7B | 16.2B | 16.4B | 15.8B | 15.2B | 15.5B | 14.9B | 14.9B | 13.7B |
| 有息負債 | 3.8B | 3.8B | 3.8B | 3.7B | 3.4B | 3.6B | 2.3B | 2.2B | 2.2B | 2.2B | 2.2B | 2.2B |
| 總負債 | 11.8B | 12.3B | 11.5B | 11.5B | 11.6B | 12.1B | 11.0B | 10.3B | 11.0B | 10.7B | 11.0B | 10.0B |
| 股東權益 | 4.2B | 4.1B | 4.1B | 4.2B | 4.6B | 4.3B | 4.8B | 4.8B | 4.5B | 4.2B | 3.9B | 3.6B |
| 負債比 | 73.9% | 75.1% | 73.9% | 73.3% | 71.6% | 73.7% | 69.7% | 68.1% | 71.0% | 71.7% | 73.9% | 73.5% |
| 淨現金(現金 − 有息負債) | 1.2B | 1.5B | 482M | 557M | 1.1B | 1.3B | 2.4B | 2.2B | 2.3B | 2.7B | 3.4B | 2.7B |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | 1.1B+469% | – | – | – | 190M | – | – | 214M | – | – | – |
| 資本支出 | – | 27.0M | – | – | – | 22.0M | – | – | 27.0M | – | – | – |
| 自由現金流 | – | 1.1B+528% | – | – | – | 168M | – | – | 187M | – | – | – |
| 折舊攤銷 | 40.0M | 39.0M | 44.0M | 45.0M | 58.0M | 48.0M | 47.0M | 46.0M | 45.0M | 43.0M | 42.0M | 42.0M |
| 買回庫藏股 | – | 0 | – | – | – | 500M | – | – | 0 | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | 9.8% | – | – | – | 1.5% | – | – | 1.9% | – | – | – |
營收拆解
這家公司的 XBRL 沒有標分部、產品或地區營收。多半是單一業務,或只在 10-K 文字裡揭露。
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | 45.4B | +11.7% | 472M | 1.0% | 8.92 | −636M |
| FY2024 | 40.7B | +19.3% | 1.2B | 2.9% | 20.42 | 544M |
| FY2023 | 34.1B | +6.6% | 1.1B | 3.2% | 18.77 | 1.6B |
| FY2022 | 32.0B | +15.1% | 792M | 2.5% | 13.55 | 682M |
| FY2021 | 27.8B | +43.0% | 659M | 2.4% | 11.25 | 2.0B |
| FY2020 | 19.4B | +15.4% | 673M | 3.5% | 11.23 | 1.8B |
| FY2019 | 16.8B | -10.9% | 737M | 4.4% | 11.47 | 377M |
| FY2018 | 18.9B | – | 707M | 3.7% | 10.61 | −344M |